Personal information

Activities

Collapse all

Employment (2)

University of Vienna: Vienna, AT

2020-09-01 to present | Professor (Pharmaceutical Chemistry)
Employment
Source: Self-asserted source
Christoph Rademacher

Max-Planck-Institut für Kolloid- und Grenzflächenforschung: Potsdam, Brandenburg, DE

2011-12-01 to 2020-08-31 | Group Leader (Biomolecular Systems)
Employment
Source: Self-asserted source
Christoph Rademacher

Education and qualifications (3)

Scripps Research Institute: La Jolla, CA, US

2009-03-01 to 2011-10-31 | Postdoctoral Researcher (Chemical Physiology)
Education
Source: Self-asserted source
Christoph Rademacher

Universität zu Lübeck: Lubeck, Schleswig-Holstein, DE

2006-10-01 to 2009-01-14 | PhD (Department of Chemistry)
Education
Source: Self-asserted source
Christoph Rademacher

Universität zu Lübeck: Lubeck, Schleswig-Holstein, DE

2004-10-01 to 2006-10-01 | Master of Science (Molecular Life Science)
Education
Source: Self-asserted source
Christoph Rademacher

Funding (8)

Modulation of platelet biology with CLEC-2 targeted liposomes

2022-06-01 to 2025-11-30 | Grant
Vienna Science and Technology Fund (Vienna, AT)
URL: https://app.dimensions.ai/details/grant/grant.10009241
GRANT_NUMBER: LS21-039
Source: Self-asserted source
Christoph Rademacher via DimensionsWizard

Ligand-based targeted delivery for murine Langerin

2021-06-01 to 2024-05-31 | Grant
FWF Austrian Science Fund (Vienna, AT)
URL: https://app.dimensions.ai/details/grant/grant.9386996
GRANT_NUMBER: I 5157
Source: Self-asserted source
Christoph Rademacher via DimensionsWizard

Immunotherapy of cancer with Langerin-ligand liposomes

2020-12-01 to 2024-11-30 | Grant
FWF Austrian Science Fund (Vienna, AT)
URL: https://app.dimensions.ai/details/grant/grant.9417398
GRANT_NUMBER: P 33855
Source: Self-asserted source
Christoph Rademacher via DimensionsWizard

Design of ligand-based targeted delivery vehicles for the murine C-type lectin receptor Langerin

2020-01-01 to present | Grant
Deutsche Forschungsgemeinschaft (Bonn, DE)
URL: https://app.dimensions.ai/details/grant/grant.9418186
GRANT_NUMBER: 441778902
Source: Self-asserted source
Christoph Rademacher via DimensionsWizard

Emergent properties of cell surface glycosylation in cell-cell communication

2017-02-01 to 2023-09-30 | Grant
European Research Council (Brussels, BE)
URL: https://app.dimensions.ai/details/grant/grant.6622968
GRANT_NUMBER: 716024
Source: Self-asserted source
Christoph Rademacher via DimensionsWizard

Cargo uptake and release of the human lectin receptor Langerin

2017-01-01 to 2021-12-31 | Grant
Deutsche Forschungsgemeinschaft (Bonn, DE)
URL: https://app.dimensions.ai/details/grant/grant.7167926
GRANT_NUMBER: 388821358
Source: Self-asserted source
Christoph Rademacher via DimensionsWizard

Developing non-carbohydrate glycomimetics targeted to bacterial lectins

2017-01-01 to 2021-12-31 | Grant
Deutsche Forschungsgemeinschaft (Bonn, DE)
URL: https://app.dimensions.ai/details/grant/grant.7168208
GRANT_NUMBER: 390973730
Source: Self-asserted source
Christoph Rademacher via DimensionsWizard

Targeting C-type lectins on dendritic cells using carbohydrate-analogs for the specific delivery of tumor vaccines

2012-01-01 to 2017-12-31 | Grant
Deutsche Forschungsgemeinschaft (Bonn, DE)
URL: https://app.dimensions.ai/details/grant/grant.4830771
GRANT_NUMBER: 213952189
Source: Self-asserted source
Christoph Rademacher via DimensionsWizard
How many people are using ORCID?